Navigation Links
Cardiometabolic Health Congress Faculty Deliver Expert Guidance on Novel Management Strategies for Diabetes and its Comorbidities
Date:10/1/2013

BOSTON, Oct. 1, 2013 /PRNewswire/ -- Critical to improving outcomes in diabetes is providing patient-centered care and encouraging shared decision-making. During a featured opening session on Friday, John Buse, MD, shares strategies for improving adherence, tailoring treatment regimens and provides an expert perspective on recent safety concerns with diabetes therapies.

Presenting state-of-the-science in insulin therapy as monotherapy or in combination with GLP-1 agonists, as well as the latest advances in managing Type 1 diabetes to prevent the microvascular and macrovascular complications of this disease, Dr. Buse will be joined by a stellar faculty to include Drs. Irl Hirsch, Robert Eckel and Jay Skyler.

With a national spotlight on high rates of childhood obesity and diabetes, Drs. Sonia Caprio and David Ludwig, renowned pediatric specialists, address the role of adolescent obesity in the pathogenesis of diabetes, the clinical and metabolic phenotypes of children with T2DM, and the clinical implications of the TODAY trial through a panel discussion. Dr. Ludwig outlines an innovative "integrative, family-based approach" for clinicians seeking to educate parents of obese children.

Friday's keynote session features another panel discussion titled "Clinical Controversies in Hypertension Management: Expert Perspectives & Discussion." In this lively exchange, Drs. Rajiv Agarwal, Raymond Townsend, and William White discuss common dilemmas facing clinicians who treat patients with comorbid hypertension and diabetes. A presentation by Robert Brook, MD, provides guidance to clinicians seeking to understand the role of alternative medicine in hypertension management.

In addition to the comprehensive array of educational sessions addressing the latest evidence and research on diabetes, cardiovascular disease, obesity and hypertension, attendees at the conference are able to choose from 14 symposia featuring presenters who are lead investigators of all recent cardiometabolic trials.

Darren McGuire, MD, said, "CMHC provides a great opportunity to catch up on the latest developments and thinking in the overlap area of insulin resistance and cardiovascular health, and is one of the only conferences in the world that brings together experts across the breadth of diabetes, obesity, and cardiovascular disease to share ideas and foster collaborations."

The 8th Annual Cardiometabolic Health Congress takes place October 2-5, 2013, in Boston.  For more information, contact Brittany Maynard at info@cardiometabolichealth.org or 877-571-4700 or visit www.cardiometabolichealth.org.

Contact: Brittany Maynard
Tel.: 877-571-4700
Email: info@cardiometabolichealth.org
Web: www.cardiometabolichealth.org


'/>"/>
SOURCE Cardiometabolic Health Congress
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Cardiometabolic Health Congress Expert Faculty Evaluate the Clinical Implications of Newly FDA-Approved Treatment for Homozygous Familial Hypercholesterolemia
2. DIA and IFAH to Host Third Global Animal Health Conference
3. Biotechs Leading the Healthcare Sector - Alliqua, Pacific Biosciences, Oncothyreon, Keryx, Organovo
4. Regado Biosciences, Inc. to Present at Aegis Capital Vegas Healthcare Conference
5. In The Face Of Increasing Healthcare Spend And High-Cost Targeted Treatment, Market Access Barriers Continue To Rise For Targeted Oncology Drugs
6. Discovery Meets Recovery in New Cedars-Sinai’s Advanced Health Sciences Pavilion Designed by HOK
7. Pets Best Insurance Announces Stem Cell Therapy and Regenerative Veterinary Medicine by Vet-Stem, Inc. Covered by Their Pet Health Insurance
8. Natural Acne Solution Explains New Developments Between Probiotic Acne Treatments and Mental Health
9. GW Pharmaceuticals to Present at the 2013 Aegis Capital Healthcare Conference
10. AtheroNova to Present at the 2013 Aegis Healthcare Conference in Las Vegas
11. Identifying Opportunities, Growth and Generating Returns for Indian Healthcare Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions ... over 5.5 million people each year. Especially those living in larger cities are affected ... based in one of the most pollution-affected countries globally - decided to take action. ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh ... orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of ... SBT-100 is able to cross the cell membrane and bind intracellular STAT3 and ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
Breaking Biology Technology:
(Date:3/24/2017)... , March 24, 2017 The Controller General ... Controller Mr. Abdulla Algeen have received the prestigious international IAIR ... Continue Reading ... ... picture) and Deputy Controller Abdulla Algeen (small picture on the right) have ...
(Date:3/23/2017)... 2017 The report "Gesture Recognition and Touchless Sensing Market ... - Global Forecast to 2022", published by MarketsandMarkets, the market is expected to ... between 2017 and 2022. Continue Reading ... ... ...
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
Breaking Biology News(10 mins):